ROCO
6469
Market cap312mUSD
Oct 08, Last price
66.40TWD
1D
2.63%
1Q
-14.87%
Jan 2017
351.09%
IPO
457.98%
Name
Great Tree Pharmacy Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Great Tree Pharmacy Co., Ltd. is a Taiwanese enterprise that operates an extensive chain of pharmacies throughout the island nation. These retail outlets offer a broad selection of goods, including prescription and over-the-counter medications, nutritional supplements, products specifically for mothers and infants, and various cosmetics. Beyond its retail presence, the company also delivers comprehensive medication procurement and coordination services to medical establishments such as individual clinics, shared outpatient facilities, and larger integrated healthcare networks. Furthermore, Great Tree Pharmacy acts as an agent for these same medical institutions, assisting them in the distribution and sale of popular health and wellness products sourced both domestically and internationally. Established in 2001, the company was initially named Tianjin Pharmaceutical Co., Ltd. before rebranding to its current designation. Its main corporate offices are located in Taoyuan City, Taiwan.
Key people
Ming-Lung Cheng
Chairman of the Board, General Manager · since 2020
Shu Yi Wu
Assistant General Manager-Finance Division, Head of Corporate Governance · since 2019
Shang-Feng Lu
Deputy General Manager, Director · since 2021
Hung Yi Chen
Director · since 2020
Li-Ping Shen
Director · since 2023
Shih Wei Yeh
Director · since 2023
Dai-Huang Kuo
Independent Director · since 2020
Tian Dao Liu
Independent Director · since 2014
Min-Hsiung Pan
Independent Director · since 2023
Hsing-Wen Wang
Independent Director · since 2020
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||